0
Upcoming Allied Market Research
2023
Chemotherapy Induced Anemia Market

Chemotherapy Induced Anemia Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A10539
Pages: NA
Jul 2023 | 960 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Chemotherapy Induced Anemia Market

Request Now !

Chemotherapy-induced anemia (CIA) is a consequence of malignant invasion of normal tissues leading to blood loss, bone marrow infiltration with disruption of erythropoiesis, and functional iron deficiency as a consequence of inflammation. CIA is a significant consequence of chemotherapy and may delay or limit therapy as well as contribute to both fatigue and diminished quality of life. Unfortunately, not all clinicians consistently survey, measure, or even document anemia-related symptoms. Furthermore, there are inconsistent thresholds for both definition and severity of anemia. It may also be defined by a reduction from baseline hemoglobin, the use of blood transfusions, or use of recombinant human erythropoietin therapy, others fail to document the toxicity grading system used to define anemia. 

COVID-19 scenario analysis:

Pharmaceutical and biotechnological companies together with governments around the globe are working to combat the COVID-19 outbreak. This is carried out by supporting development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have seen huge boost in demand for management of COVID-19. There is an increase in demand for the drug, which has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of the drug. Hence, owing  to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the chemotherapy induced anemia market includes surge in occurrence of anemia and cancer among geriatric population. This is anticipated to boost the industry during the forecast period. Furthermore, increase in chronic conditions and rise in number of pipeline products is expected to help the industry gain traction. There has been a rise in innovations of the technology and the government policies are turning out to be favorable such that, it would help the market gain higher revenue in the next few years.

Growth in the number of product developments to boost the market

Growth in number of product developments would help the industry flourish during the forecast period. For instance, in September 2019, FibroGen, Inc. announced first patient dosed in the company’s Phase 2 clinical study of roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of chemotherapy-induced anemia (CIA) in cancer patients receiving chemotherapy.

Roxadustat has been studied in anemia associated with chronic kidney disease in global Phase 3 studies enrolling over 9,000 patients, and is approved for treatment of anemia in CKD patients on dialysis and not on dialysis in China, and in CKD patients on dialysis in Japan, with preparation of the U.S. NDA submission and the European MAA submission underway.

Furthermore, in July 2020, Drug firm Zydus Cadila had received approval from the US health regulator to initiate clinical trials for its drug ‘Desidustat’ in treatment of chemotherapy-induced anemia.

Surge in number of mergers and acquisitions to propel the market

Increase in number of mergers and acquisitions is anticipated to help the industry grow in the coming years. For instance, in October 2019, Dova Pharmaceuticals acquired by Swedish Orphan Biovitrum AB (Sobi) for up to $915m, dependent on the regulatory approval of its lead drug Doptelet in a new indication. Under the terms of the agreement, Sobi offered a consideration of up to $29 per share to Dova stockholders, with an upfront consideration pf $27.50 per share and an additional $1.50 per share upon approval of Doptelet (avatrombopag) for chemotherapy-induced thrombocytopenia (CIT). This amounts to a total potential consideration of up to $915m.

Doptelet is Dova’s first product to receive approval from the FDA as a treatment for low platelet counts (thrombocytopenia) in patients with chronic liver disease, who have to undergo a medical procedure. This was then expanded to patients with chronic immune thrombocytopenia (ITP), who were not benefitted from previous treatment.

Key benefits of the report:

  • This study presents the analytical depiction of the global chemotherapy induced anemia industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global chemotherapy induced anemia market share.
  • The current market is quantitatively analyzed to highlight the global chemotherapy induced anemia market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the chemotherapy induced anemia market.
  • The report provides a detailed global chemotherapy induced anemia market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the chemotherapy induced anemia market research report:

  • Which are the leading market players active in the chemotherapy induced anemia market?
  • What would be the detailed impact of COVID-19 on the chemotherapy induced anemia market?
  • What current trends would influence the chemotherapy induced anemia market in the next few years?
  • What are the driving factors, restraints, and opportunities in the chemotherapy induced anemia market?
  • What are the projections for the future that would help in taking further strategic steps?

Chemotherapy Induced Anemia Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Range of Anemia
  • Mild Anemia
  • Moderate Anemia
  • Severe Anemia
  • Life-threatening Anemia
By Treatment Type
  • RBC Transfusions
  • Erythropoiesis-stimulating agents (ESAs)
  • Iron Supplementation
By Drug Type
  • Epogen Injection
  • Procrit Injection
  • Androxy Oral
  • Aranesp injection
  • Epoetin Alfa Injection
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Multispecialty Clinics
  • Cancer Research Centers
  • Cancer Rehabilitation Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Pfizer Inc.,, Panacea Biotec.,, Panacea, Biotec Limited,, 3SBio Inc.,, SBI Pharmaceuticals Co., Ltd,, Dr. Reddy’s Laboratories Ltd.,, Tolero Pharmaceuticals, Inc.,, Vifor Pharma AG,, Therapure Biopharma Inc.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Chemotherapy Induced Anemia Market

Start reading.
This Report and over 52,864+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers